We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Biocartis SA

Biocartis is a commercial stage molecular diagnostics company that develops diagnostics technology platforms for mult... read more Featured Products: More products

Download Mobile App




Influenza-Respiratory Virus Panel Launched for Idylla platform

By LabMedica International staff writers
Posted on 09 Dec 2015
Print article
The Idylla fully automated, real-time polymerase chain reaction based molecular diagnostics system
The Idylla fully automated, real-time polymerase chain reaction based molecular diagnostics system (Photo courtesy of Biocartis SA)
The majority of diagnostic tests currently used for respiratory viruses are rapid immunoassays which are chosen due to their low cost and convenience; however, one of the key downsides of these rapid tests is their poor sensitivity.

A fully automated, real-time polymerase chain reaction (PCR) based molecular diagnostics system, which is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime has been launched for the diagnosis of respiratory infectious diseases.

The platform covers the entire process from sample to result in a time frame of 35 to 150 minutes with less than two minutes hands-on time. The platform is applicable for a wide range of clinical sample types and can analyze both ribonucleic acid (RNA) and DNA. A new panel for the platform is intended for the detection of various strains of Influenza Virus (IFV) and Respiratory Syncytial Virus (RSV).

The Idylla Respiratory IFV-RSV Panel (Biocartis Group NV; Mechelen, Belgium) is designed for the qualitative detection of nucleic acids of Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype 2009 H1, H275Y mutation of Influenza A subtype 2009 H1, Influenza B and Respiratory Syncytial Virus (RSV) subtype A and RSV subtype B from nasopharyngeal swabs of adult and pediatric patients. The panel uses the Idylla molecular diagnostics platform to aid in the diagnosis of respiratory viral infection. The Idylla Respiratory IFV-RSV Panel received CE-IVD marking on November 18, 2015, and is being launched for commercial use in Europe and other countries recognizing the CE-marking. Janssen Diagnostics (Raritan, NJ, USA) has appointed Biocartis as co-exclusive worldwide distributor of the test.

Rudi Pauwels, PhD, CEO of Biocartis, said, “Collaboration is a key aspect of the strategy that we outlined at the time of our Initial Public Offering, in order to accelerate our menu development and speed up our commercial reach. Janssen has been a long-standing and very supportive partner of Biocartis. We are therefore delighted with the launch of such a high performance quality Idylla Respiratory IFV-RSV Panel. The combination of oncology and infectious disease tests demonstrates the versatility of our Idylla platform, one of the reasons why Janssen Diagnostics chose to work with Biocartis.”

Related Links:

Biocartis Group NV 
Janssen Diagnostics 


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Urine Strips
11 Parameter Urine Strips
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.